1. Home
  2. SERV vs IVA Comparison

SERV vs IVA Comparison

Compare SERV & IVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Serve Robotics Inc.

SERV

Serve Robotics Inc.

HOLD

Current Price

$10.33

Market Cap

724.7M

ML Signal

HOLD

Logo Inventiva S.A. American Depository Shares

IVA

Inventiva S.A. American Depository Shares

HOLD

Current Price

$4.63

Market Cap

804.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SERV
IVA
Founded
2017
2011
Country
United States
France
Employees
N/A
N/A
Industry
Industrial Specialties
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
724.7M
804.2M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
SERV
IVA
Price
$10.33
$4.63
Analyst Decision
Buy
Strong Buy
Analyst Count
6
7
Target Price
$18.20
$17.14
AVG Volume (30 Days)
7.7M
237.4K
Earning Date
11-12-2025
09-29-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,944,483.00
$19,929,536.00
Revenue This Year
$44.11
N/A
Revenue Next Year
$891.96
N/A
P/E Ratio
N/A
N/A
Revenue Growth
15.76
N/A
52 Week Low
$4.66
$2.11
52 Week High
$24.35
$7.98

Technical Indicators

Market Signals
Indicator
SERV
IVA
Relative Strength Index (RSI) 46.16 56.56
Support Level $9.77 $4.12
Resistance Level $11.22 $4.58
Average True Range (ATR) 0.80 0.20
MACD -0.10 0.04
Stochastic Oscillator 20.19 85.83

Price Performance

Historical Comparison
SERV
IVA

About SERV Serve Robotics Inc.

Serve Robotics Inc is developing next-generation robots for last-mile delivery services. It design, develop and operate low-emissions robots on AI-powered robotics mobility platform, that serve people in public spaces, starting with food delivery. Its first product is a zero-emission robot that serves people in public areas, Starting with food delivery. It has developed an AI-robotics mobility platform, with last-mile delivery in cities as its first application.

About IVA Inventiva S.A. American Depository Shares

Inventiva SA is a France-based biopharmaceutical company specialized in developing drugs that impact on nuclear receptors, transcription factors and epigenetic modulation. The company is focused on developing its product candidate, lanifibranor, for the treatment of patients with non-alcoholic steatohepatitis, or NASH, a disease for which there are currently no approved therapies. The company is also involved in developing a portfolio of pre-clinical therapy programs. It operates in the segment of Service delivery and clinical stage research, notably into therapies in the areas of oncology, fibrosis, and rare diseases. All the company's operations are in France. Majority of the group's revenue is derived from its research partnerships with AbbVie and BI.

Share on Social Networks: